Biogen cov khoom lag luam poob 3.7% tom qab tshaj tawm cov nyiaj tau los, hais tias nws tau nqa $ 1 lab hauv kev muag tshuaj Alzheimer hauv lub quarter thib plaub.

Ib qho dhau los ntawm tsab ntawv ceeb toom no muaj qhov kev pom zoo tsis raug thiab tus lej nyiaj tau los. Nws tau raug kho lawm.

Shares ntawm Biogen Inc.
PIB,
-1.92%
tau nqis 3.7% hauv kev ua lag luam ua ntej hnub Thursday tom qab lub tuam txhab tau tshaj tawm cov lus qhia tshiab rau 2022. Biogen tau nyiaj tau los ntawm $ 368.2 lab, lossis $ 2.50 ib feem, hauv lub quarter thib plaub ntawm 2021, piv nrog $ 357.9 lab, lossis $ 2.33 ib feem, hauv plaub. peb lub hlis twg ib xyoos dhau los. Nws tau kho cov nyiaj khwv tau los ntawm ib feem ntawm $ 3.39, tawm tsam FactSet kev pom zoo ntawm $ 3.37. Biogen tau tshaj tawm cov nyiaj tau los ntawm $ 2.7 nphom hauv peb lub hlis kawg ntawm lub xyoo, nqis los ntawm $ 2.8 billion ib xyoos dhau los. Qhov kev pom zoo ntawm FactSet yog $ 2.6 billion. Nws cov tshuaj ntau-sclerosis Tysabri tseem yog nws cov tshuaj muag muag, nqa $ 512.7 lab hauv cov nyiaj tau los hauv lub quarter thib plaub, thaum Spinraza, kev kho tus txha caj qaum, muaj $ 440.7 lab hauv kev muag khoom. Lub tuam txhab cov tshuaj Alzheimer's kab mob tsim tau $ 1 lab hauv kev muag khoom hauv lub quarter thib plaub thiab tag nrho $ 3 lab hauv kev muag khoom rau lub xyoo txij li nws tau txais kev pom zoo hauv Asmeskas thaum Lub Rau Hli. Biogen kuj tau hais tias nws cia siab tias yuav muaj kev tshaj tawm tsis ntev los no nrog Samsung Biologics Co.
207940,
+ 4.47%
muag $ 2.3 billion ceg txheem ntseeg hauv Samsung Bioepis yuav kaw nyob rau nruab nrab-2022. Nws tau tshaj tawm cov lus qhia rau 2022, hais tias nws cia siab tias cov nyiaj tau los ntawm $ 9.7 billion thiab $ 10.0 billion thiab kho EPS ntawm $ 14.25 thiab $ 16.00. Qhov kev pom zoo FactSet yog $18.76. Biogen cov khoom lag luam poob qis 14.5% xyoo dhau los, thaum qhov dav S&P 500
SPX,
+ 0.94%
yog nce 19.9%.

Source: https://www.marketwatch.com/story/biogens-stock-falls-37-on-earnings-miss-says-it-brought-in-1-million-in-sales-of-alzheimers-drug-in-the-fourth-quarter-2022-02-03?siteid=yhoof2&yptr=yahoo